Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
 1件: RARA 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
2 Adrenergic signaling in cardiomyocytes 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
3 AGE-RAGE signaling pathway in diabetic complications 💬
 2件: VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
4 Alanine, aspartate and glutamate metabolism 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
5 Alcoholism 💬
 1件: DDC 💬 D00558 💬 Carbidopa 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
6 Alcoholism 💬
 2件: DRD1, DRD2 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
7 Aldosterone synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
8 Aldosterone synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
9 Alzheimer disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
10 Alzheimer disease 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
11 Amphetamine addiction 💬
 2件: CACNA1C, CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
12 Amphetamine addiction 💬
 1件: DDC 💬 D00558 💬 Carbidopa 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
13 Amphetamine addiction 💬
 1件: DRD1 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
14 Amphetamine addiction 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
15 Amyotrophic lateral sclerosis 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
16 Apoptosis - multiple species 💬
 1件: NGFR 💬 D11028 💬 Cenegermin 2件: 53, 90 💬
17 Arrhythmogenic right ventricular cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
18 Axon guidance 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
19 B cell receptor signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
20 beta-Alanine metabolism 💬
 3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
21 Bile secretion 💬
 1件: CA2 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
22 Bile secretion 💬
 1件: CA2 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
23 Bile secretion 💬
 1件: CA2 💬 D00653 💬 Dorzolamide 1件: 90 💬
24 Bile secretion 💬
 1件: CA2 💬 D07871 💬 Dorzolamide 1件: 90 💬
25 Bladder cancer 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
26 Butanoate metabolism 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
27 C-type lectin receptor signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
28 Calcium signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
29 Calcium signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
30 Calcium signaling pathway 💬
 2件: DRD1, DRD5 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
31 Calcium signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
32 Calcium signaling pathway 💬
 1件: PTGFR 💬 D08661 💬 Unoprostone 1件: 90 💬
33 Calcium signaling pathway 💬
 2件: VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
34 cAMP signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
35 cAMP signaling pathway 💬
 3件: DRD1, DRD2, DRD5 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
36 Carbohydrate digestion and absorption 💬
 1件: CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
37 Cardiac muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
38 Cellular senescence 💬
 1件: CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
39 Cellular senescence 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
40 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D02076 💬 Brimonidine 2件: 13, 90 💬
41 cGMP-PKG signaling pathway 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D07540 💬 Brimonidine 2件: 13, 90 💬
42 cGMP-PKG signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
43 cGMP-PKG signaling pathway 💬
 1件: PDE5A 💬 D02229 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
44 cGMP-PKG signaling pathway 💬
 1件: PDE5A 💬 D08514 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
45 cGMP-PKG signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
46 Chemical carcinogenesis - reactive oxygen species 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
47 Chemical carcinogenesis - receptor activation 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
48 Chemical carcinogenesis - receptor activation 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
49 Cholinergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
50 Circadian entrainment 💬
 2件: CACNA1C, CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
51 Circadian entrainment 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
52 Circadian entrainment 💬
 2件: MTNR1A, MTNR1B 💬 D08170 💬 Melatonin 12件:  6 ,  8 , 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 💬
53 Cocaine addiction 💬
 1件: DDC 💬 D00558 💬 Carbidopa 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
54 Cocaine addiction 💬
 2件: DRD1, DRD2 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
55 Collecting duct acid secretion 💬
 1件: CA2 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
56 Collecting duct acid secretion 💬
 1件: CA2 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
57 Collecting duct acid secretion 💬
 1件: CA2 💬 D00653 💬 Dorzolamide 1件: 90 💬
58 Collecting duct acid secretion 💬
 1件: CA2 💬 D07871 💬 Dorzolamide 1件: 90 💬
59 Cortisol synthesis and secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
60 Cortisol synthesis and secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
61 Cushing syndrome 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
62 Cushing syndrome 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
63 Cytokine-cytokine receptor interaction 💬
 1件: NGFR 💬 D11028 💬 Cenegermin 2件: 53, 90 💬
64 Dilated cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
65 Dopaminergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
66 Dopaminergic synapse 💬
 1件: DDC 💬 D00558 💬 Carbidopa 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
67 Dopaminergic synapse 💬
 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
68 Dopaminergic synapse 💬
 3件: PPP3CA, PPP3CB, PPP3CC 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
69 EGFR tyrosine kinase inhibitor resistance 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
70 Estrogen signaling pathway 💬
 1件: RARA 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
71 Fluid shear stress and atherosclerosis 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
72 Focal adhesion 💬
 3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
73 GABAergic synapse 💬
 3件: ABAT, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
74 GABAergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
75 Gap junction 💬
 2件: DRD1, DRD2 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
76 Gastric acid secretion 💬
 1件: CA2 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
77 Gastric acid secretion 💬
 1件: CA2 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
78 Gastric acid secretion 💬
 1件: CA2 💬 D00653 💬 Dorzolamide 1件: 90 💬
79 Gastric acid secretion 💬
 1件: CA2 💬 D07871 💬 Dorzolamide 1件: 90 💬
80 Gastric cancer 💬
 1件: RARB 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
81 Glucagon signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
82 Glutamatergic synapse 💬
 2件: CACNA1C, CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
83 Glutamatergic synapse 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
84 GnRH secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
85 GnRH secretion 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
86 GnRH signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
87 Growth hormone synthesis, secretion and action 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
88 HIF-1 signaling pathway 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
89 Human cytomegalovirus infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
90 Human cytomegalovirus infection 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
91 Human immunodeficiency virus 1 infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
92 Human papillomavirus infection 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
93 Human T-cell leukemia virus 1 infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
94 Hypertrophic cardiomyopathy 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
95 Insulin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
96 Kaposi sarcoma-associated herpesvirus infection 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
97 Kaposi sarcoma-associated herpesvirus infection 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
98 Lipid and atherosclerosis 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
99 Long-term potentiation 💬
 1件: CACNA1C 💬 D01908 💬 Nilvadipine 1件: 90 💬
100 Long-term potentiation 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
101 MAPK signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
102 MAPK signaling pathway 💬
 3件: CACNA1G, CACNA1H, CACNA1I 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
103 MAPK signaling pathway 💬
 1件: NGFR 💬 D11028 💬 Cenegermin 2件: 53, 90 💬
104 MAPK signaling pathway 💬
 3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
105 MAPK signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
106 Metabolic pathways 💬
 4件: ABAT, ALDH5A1, GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
107 Metabolic pathways 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
108 Metabolic pathways 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
109 Metabolic pathways 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D00653 💬 Dorzolamide 1件: 90 💬
110 Metabolic pathways 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D07871 💬 Dorzolamide 1件: 90 💬
111 Metabolic pathways 💬
 1件: DDC 💬 D00558 💬 Carbidopa 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
112 Metabolic pathways 💬
 1件: PDE5A 💬 D02229 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
113 Metabolic pathways 💬
 1件: PDE5A 💬 D08514 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
114 MicroRNAs in cancer 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
115 Morphine addiction 💬
 1件: DRD1 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
116 Natural killer cell mediated cytotoxicity 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
117 Neuroactive ligand-receptor interaction 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D02076 💬 Brimonidine 2件: 13, 90 💬
118 Neuroactive ligand-receptor interaction 💬
 3件: ADRA2A, ADRA2B, ADRA2C 💬 D07540 💬 Brimonidine 2件: 13, 90 💬
119 Neuroactive ligand-receptor interaction 💬
 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
120 Neuroactive ligand-receptor interaction 💬
 2件: MTNR1A, MTNR1B 💬 D08170 💬 Melatonin 12件:  6 ,  8 , 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 💬
121 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00244 💬 Betamethasone 7件:  2 , 28, 46, 83, 90, 96, 235 💬
122 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00972 💬 Betamethasone 7件:  2 , 28, 46, 83, 90, 96, 235 💬
123 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D01357 💬 Betamethasone 7件:  2 , 28, 46, 83, 90, 96, 235 💬
124 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D01402 💬 Betamethasone 7件:  2 , 28, 46, 83, 90, 96, 235 💬
125 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D01637 💬 Betamethasone 7件:  2 , 28, 46, 83, 90, 96, 235 💬
126 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D02032 💬 Betamethasone 7件:  2 , 28, 46, 83, 90, 96, 235 💬
127 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D02286 💬 Betamethasone 7件:  2 , 28, 46, 83, 90, 96, 235 💬
128 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00292 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
129 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00975 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
130 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D01510 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
131 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D01615 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
132 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D01632 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
133 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D01948 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
134 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D02174 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
135 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D02591 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
136 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D02592 💬 Dexamethasone 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬
137 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D01825 💬 Fluocinolone acetonide 1件: 90 💬
138 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00385 💬 Triamcinolone 10件: 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 💬
139 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00983 💬 Triamcinolone 10件: 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 💬
140 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00984 💬 Triamcinolone 10件: 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 💬
141 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D00985 💬 Triamcinolone 10件: 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 💬
142 Neuroactive ligand-receptor interaction 💬
 1件: NR3C1 💬 D06216 💬 Triamcinolone 10件: 35, 46, 56, 70, 90, 96, 107, 162, 226, 298 💬
143 Neuroactive ligand-receptor interaction 💬
 1件: PTGFR 💬 D08661 💬 Unoprostone 1件: 90 💬
144 Neurotrophin signaling pathway 💬
 1件: NGFR 💬 D11028 💬 Cenegermin 2件: 53, 90 💬
145 Nitrogen metabolism 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
146 Nitrogen metabolism 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
147 Nitrogen metabolism 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D00653 💬 Dorzolamide 1件: 90 💬
148 Nitrogen metabolism 💬
 13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬 D07871 💬 Dorzolamide 1件: 90 💬
149 Non-small cell lung cancer 💬
 1件: RARB 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
150 Oocyte meiosis 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
151 Osteoclast differentiation 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
152 Oxytocin signaling pathway 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
153 Oxytocin signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
154 Pancreatic cancer 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
155 Pancreatic secretion 💬
 1件: CA2 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
156 Pancreatic secretion 💬
 1件: CA2 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
157 Pancreatic secretion 💬
 1件: CA2 💬 D00653 💬 Dorzolamide 1件: 90 💬
158 Pancreatic secretion 💬
 1件: CA2 💬 D07871 💬 Dorzolamide 1件: 90 💬
159 Parkinson disease 💬
 2件: DRD1, DRD2 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
160 Pathways in cancer 💬
 3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
161 Pathways in cancer 💬
 2件: RARA, RARB 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
162 Pathways of neurodegeneration - multiple diseases 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
163 Pathways of neurodegeneration - multiple diseases 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
164 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
165 Phenylalanine metabolism 💬
 1件: DDC 💬 D00558 💬 Carbidopa 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
166 Phospholipase D signaling pathway 💬
 1件: PTGFR 💬 D08661 💬 Unoprostone 1件: 90 💬
167 PI3K-Akt signaling pathway 💬
 1件: NGFR 💬 D11028 💬 Cenegermin 2件: 53, 90 💬
168 PI3K-Akt signaling pathway 💬
 3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
169 Prion disease 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
170 Prion disease 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
171 Propanoate metabolism 💬
 1件: ABAT 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
172 Proteoglycans in cancer 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
173 Proximal tubule bicarbonate reclamation 💬
 2件: CA2, CA4 💬 D00218 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
174 Proximal tubule bicarbonate reclamation 💬
 2件: CA2, CA4 💬 D01196 💬 Acetazolamide 8件: 13, 86, 90, 115, 154, 155, 225, 230 💬
175 Proximal tubule bicarbonate reclamation 💬
 2件: CA2, CA4 💬 D00653 💬 Dorzolamide 1件: 90 💬
176 Proximal tubule bicarbonate reclamation 💬
 2件: CA2, CA4 💬 D07871 💬 Dorzolamide 1件: 90 💬
177 Purine metabolism 💬
 1件: PDE5A 💬 D02229 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
178 Purine metabolism 💬
 1件: PDE5A 💬 D08514 💬 Sildenafil 17件:  6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
179 Rap1 signaling pathway 💬
 1件: DRD2 💬 D00059 💬 Levodopa 8件:  2 ,  4 ,  6 , 17, 90, 140, 164, 201 💬
180 Rap1 signaling pathway 💬
 1件: NGFR 💬 D11028 💬 Cenegermin 2件: 53, 90 💬
181 Rap1 signaling pathway 💬
 3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
182 Ras signaling pathway 💬
 1件: NGFR 💬 D11028 💬 Cenegermin 2件: 53, 90 💬
183 Ras signaling pathway 💬
 3件: PGF, VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
184 Relaxin signaling pathway 💬
 2件: VEGFA, VEGFB 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
185 Renal cell carcinoma 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
186 Renin secretion 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
187 Renin secretion 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
188 Retrograde endocannabinoid signaling 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
189 Rheumatoid arthritis 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
190 Serotonergic synapse 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
191 Serotonergic synapse 💬
 1件: DDC 💬 D00558 💬 Carbidopa 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
192 Small cell lung cancer 💬
 1件: RARB 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
193 T cell receptor signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
194 Taste transduction 💬
 1件: CACNA1C 💬 D01908 💬 Nilvadipine 1件: 90 💬
195 Taurine and hypotaurine metabolism 💬
 2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
196 Th1 and Th2 cell differentiation 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
197 Th17 cell differentiation 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
198 Th17 cell differentiation 💬
 1件: RARA 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
199 Tight junction 💬
 1件: CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
200 Transcriptional misregulation in cancer 💬
 1件: NGFR 💬 D11028 💬 Cenegermin 2件: 53, 90 💬
201 Transcriptional misregulation in cancer 💬
 1件: RARA 💬 D06543 💬 Vitamin A 3件: 13, 53, 90 💬
202 Tryptophan metabolism 💬
 1件: DDC 💬 D00558 💬 Carbidopa 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
203 Tuberculosis 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
204 Type I diabetes mellitus 💬
 2件: GAD1, GAD2 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
205 Type II diabetes mellitus 💬
 2件: CACNA1C, CACNA1D 💬 D01908 💬 Nilvadipine 1件: 90 💬
206 Type II diabetes mellitus 💬
 1件: CACNA1G 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
207 Tyrosine metabolism 💬
 1件: DDC 💬 D00558 💬 Carbidopa 9件:  2 ,  4 ,  6 , 13, 17, 90, 140, 164, 201 💬
208 Valine, leucine and isoleucine degradation 💬
 1件: ABAT 💬 D00399 💬 Valproic acid 17件:  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 127, 222, 233, 256, 331 💬
209 Vascular smooth muscle contraction 💬
 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 D01908 💬 Nilvadipine 1件: 90 💬
210 VEGF signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
211 VEGF signaling pathway 💬
 1件: VEGFA 💬 D09574 💬 Aflibercept 2件: 90, 166 💬
212 Wnt signaling pathway 💬
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine 44件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬

先頭へ